InvestorsHub Logo
Followers 2
Posts 355
Boards Moderated 0
Alias Born 01/26/2007

Re: None

Friday, 11/29/2013 11:12:03 AM

Friday, November 29, 2013 11:12:03 AM

Post# of 489
11-29-2013 Following posted on company website:
Company to receive Aladdin machines in Wakefield, MA Facility

The Company will receive two sequentially interactive Aladdin machines currently under construction which will be delivered to its Wakefield facility for testing in approx. 6 weeks.
The machines will be operated in a manner that one machine will be extracting gold while the other is being loaded with recycled chemicals from the previous run. This system allows the Company to perform detailed system and component evaluation studies and will allow for bulk testing and client demonstrations of the technology while training Company personnel for future commercial operations.
Confidentiality agreements preclude further detail at this time but updates will be given when appropriate

JOINT VENTURE TO DEVELOP EMP PROTOCOLS

The Company is pleased to announce the establishment of a joint venture with Oppenheimer Enterprises LLC to develop EMP protocols. Dr. Les Oppenheimer had worked closely with Norman Haber during the initial development of EMP. He was the chief scientist instrumental in the development of the protocols presented in publication for The National Academy of Sciences Paper (vol.79 no.2, 1982) which presented Norman's Electromolecular Propulsion as a distinctly different process from it's classical counterparts. The Paper was sponsored by Nobel Prize recipient and noted biochemist and geneticist Rollin Hotchkiss. Among the Novel attributes of EMP is the speed of molecular separation unparalleled by current technologies. These EMP qualities remain to this day relevant in the separation sciences.


The purpose of the JV will be to develop "benign" reagents to be used in proteomics to separate clinically significant molecules within a few minutes. Having benign reagents will be advantageous in the handling and permitting commercialization of the process.Haber Inc. will have the patent rights to all technology developed and Oppenheimer Industries will be entitled to a percentage of the total profits derived thereof.

Work is currently being conducted at the Picatinny Arsenal in New Jersey.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.